Simultaneous monitoring of selective serotonin reuptake inhibitors in human urine, plasma and oral fluid by reverse-phase high performance liquid chromatography

Journal of Chromatographic Science

Volumn 51, Issue 2, 2013, Pages 146-154

  Das, Ruchita ^a   Agrawal, Y K ^a  

^a GUJARAT FORENSIC SCIENCES UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN UPTAKE INHIBITOR;

ARTICLE; BLOOD; CHEMISTRY; DRUG MONITORING; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; METHODOLOGY; REGRESSION ANALYSIS; REPRODUCIBILITY; REVERSED PHASE LIQUID CHROMATOGRAPHY; SENSITIVITY AND SPECIFICITY; URINE;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, REVERSE-PHASE; DRUG MONITORING; DRUG STABILITY; HUMANS; LEAST-SQUARES ANALYSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEROTONIN UPTAKE INHIBITORS;

EID: 84872713177     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/bms119     Document Type: Article

References (49)

1. Potter, W.Z., Hollister, L.E.; Lange: Basic, clinical pharmacology-Antidepressant agent. Katzung, B.G., (ed). McGraw-Hill Company, New York, NY, (2007), pp. 475-480.
2. Goodman, L.S., Hardman, G.J., Limbird, L.E., Gilman, A.G. (eds). Goodman & Gilman's: The pharmacological basis of therapeutics. McGraw-Hill Company, New York, NY, (2001), pp. 447-483.
3. Bauer, M.; Prescribing patterns of antidepressants in Europe: Results from the Factors Influencing Depression Endpoints Research (FINDER) study; Journal of European Psychiatry, (2008); 23: 66-67.
4. Wille, S.M.R., De Letter, E.A., Michel, H.A.P., Overschelde, L., Carlos, H.V.P., Willy, E.L.; Determination of antidepressants in human postmortem blood, brain tissue, and hair using gas chromatography-mass spectrometry; International Journal of Legal Medicine, (2009); 123: 451-458.
5. Hall, W.D., Mant, A., Mitchell, P.B., Rendle, V.A., Hickie, I.B., McManus, P.; Association between antidepressant prescribing and suicide in Australia, 1991-2000: trend analysis; Journal of Biomedical Chromatography, (2003); 326: 1008-1011. (Pubitemid 36566858)
6. Isacsson, G.; Suicide prevention: A medical breakthroughActa Psychiatry Science, (2000); 102: 113-117.
7. Adamowicz, P., Kaa, M.; Simultaneous screening for and determination of 128 date-rape drugs in urine by gas chromatography-electron ionization-mass spectrometry; Forensic Science International, (2010); 198: 39-45.
8. Lacassie, J., Leo, J.; Serotonin and depression: A disconnect between the advertisements and the scientific literature, PLoS Medicine, (2005); 2: 392.
9. Uz, T., Ahmed, R., Akhisaroglu, M., Kurtuncu, M., Imbesi, M., Arslan, A.D., et al.; Effect of fluoxetine and cocaine on the expression of clock genes in the mouse hippocampus and striatum; Neuroscience, (2005); 134: 1309-1316. (Pubitemid 41207379)
10. Li, C., Ji, Z., Nan, F., Fajun, S., Shao, Q., Liu, P., et al., Liquid chromatography/tandem mass spectrometry for the determination of fluoxetine and its main active metabolite norfluoxetine in human plasma with deuterated fluoxetine as internal standard; Rapid Communication in Mass Spectrometry, (2002); 16: 1844-1850.
11. Pistos, C., Panderi, I., Atta-Politou, J.; Liquid chromatography-positive ion electrospray mass spectrometry method for the quantification of citalopram in human plasma; Journal of Chromatography B, (2004); 810: 235-244. (Pubitemid 39243310)
12. Lacassie, E., Gaulier, J.M., Marquet, P., Rabatel, J.F., Lachatre, G.; Methods for the determination of seven selective serotonine reuptake inhibitors and three active metabolites in human serum using high-performance liquid chromatography and GC; Journal of Chromatography B, 742: (2000); 229-238. (Pubitemid 30331040)
13. Berzas, J.J., Villasenor, M.J., Contento, A.M., Aguas, E.; Determination of fluoxetine, fluvoxamine, and clomipramine in pharmaceutical formulations by capillary gas chromatography; Journal of Chromatographic Science, (2000); 38: 200-206.
14. Crifasi, J.A., Le, N.X., Long, C.; Simultaneous identification and quantitation of fluoxetine and its metabolite, norfluoxetine, in biological samples by GC-MS; Journal of Analytical Toxicology, (1997); 21: 415-419. (Pubitemid 27413684)
15. Rodriguez-Flores, J., Berzas-Nevado, J.J., Contento, A.M., Cabello-Diaz, M.P.; Development of a capillary zone electrophoretic method to determine six antidepressants in their pharmaceutical preparations. Experimental design for evaluating the ruggedness of method; Journal of Separation Science, (2004); 27: 33-40.
16. Cherkaoui, S., Rudaz, S., Veuthey, J.L.; Nonaqueous capillary electrophoresis-mass spectrometry for separation of venlafaxine and its phase I metabolites; Electrophoresis, (2001); 22: 491-496. (Pubitemid 32166572)
17. Pucci, V., Fanali, S., Sabbioni, C., Raggi, M.A.; Separation of five recently commercialized selective serotonin reuptake inhibitor antidepressants by capillary electrophoresis; Journal of Separation Science, (2002); 25: 1096-1100. (Pubitemid 36040695)
18. Flores, J.R., Salcedo, A.M.C., Llerena, M.J.V., Fernandez, L.M.; Micellar electrokinetic chromatographic method for the determination of letrozole, citalopram and their metabolites in human urine; Journal of Chromatography A, (2008); 1185: 281-290.
19. Vela, M.H., Quinaz Garcia, M.B., Montenegro, M.C.B.S.M.; Electrochemical behaviour of sertraline at a hanging mercury drop electrode and its determination in pharmaceutical products; Journal of Analytical and Bioanalytical Chemistry, (2001); 369: 563-566.
20. Suckow, R.F., Zhang, M.F., Cooper, T.B.; Sensitive and selective liquid-chromatographic assay of fluoxetine and norfluoxetine in plasma with fluorescence detection after precolumn derivatization; Journal of Clinical Chemistry (1992); 138: 1756-1761.
21. Esrafili, A., Yamini, Y., Shariati, S.; Hollow fiber-based liquid phase microextraction combined with high-performance liquid chromatography for extraction and determination of some antidepressant drugs in biological fluids; Analytica Chimica Acta, (2007); 604: 127-133. (Pubitemid 350046252)
22. Reddy, B.V., Reddy, K.V.N.S., Sreeramulu, J., Kanumula, G.V.; Simultaneous determination of olanzapine and fluoxetine by HPLC; Chromatographia, (2007); 66: 111-114. (Pubitemid 47030171)
23. Koves, E.M.; Use of high-performance liquid chromatography-diode array detection in forensic toxicology; Journal of Chromatography A, (1995); 692: 103-110.
24. McIntyre, I.M., King, C.V., Skafidis, S., Drummer, O.H.; Dual ultraviolet wavelength high performance liquid chromatographic method for the forensic or clinical analysis of seventeen antidepressants and some selected metabolites; Journal of Chromatography B, (1993); 62: 1215-1223.
25. de Castro, A., Concheiro, M., Quintela, O., Cruz, A., Lopez-Rivadulla, M.; LC-MS/MS method for the determination of nine antidepressants and some of their main metabolites in oral fluid and plasma: Study of correlation between venlafaxine concentrations in both matrices; Journal of Pharmaceutical and Biomedical Analysis, (2008); 48: 183-193.
26. Raggi, M.A., Pucci, V., Mandrioli, R., Sabbioni, C., Fanali, S.; Determination of recent antidepressant citalopram in human plasma by liquid chromatography-fluorescence detection; Chromatographia, (2003); 57: 273-279.
27. Zheng, M.M., Wanga, S.T., Hua, W.K., Feng, Y.Q.; In-tube solid-phase microextraction based on hybrid silica monolith coupled to liquid chromatography-mass spectrometry for automated analysis of ten antidepressants in human urine and plasma; Journal of Chromatography A, (2010); 1217: 7493-7501.
28. Fernandes, C., Jiayu, P., Sandra, P., Lancas, F.M.; Stir bar sorptive extraction-LC-MS for the analysis of fluoxetine in plasma; Chromatographia, (2006); 64: 517-521. (Pubitemid 44914982)
29. Tournel, G., Houdret, N., Hédouin, V., Deveaux, M., Gosset, D., Lhermitte, M.; High-performance liquid chromatographic method to screen and quantitate seven selective serotonin reuptake inhibitors in human serum; Journal of Chromatography B, (2001); 761: 147-158. (Pubitemid 32817104)
30. Martinez, M.A., de la Torre, C.S., Almarza, E.; Simultaneous determination of viloxazine, venlafaxine, imipramine, desipramine, sertraline, and amoxapine in whole blood: Comparison of two extraction/cleanup procedures for capillary gas chromatography with nitrogen-phosphorus detection; Journal of Analytical Toxicology, (2002); 26: 296-302. (Pubitemid 34804136)
31. Aymard, G., Livi, P., Pham, Y.T., Diquet, B.; Sensitive and rapid methods for the simultaneous quantification of five antidepressants with their respective metabolites in plasma using highperformance liquid chromatography with diode-Array detection; Journal of Chromatography B, (1997); 700: 183-189. (Pubitemid 27473991)
32. Bickeboller-Friedrich, J., Maurer, H.H.; Screening for the detection of new antidepressants, neuroleptics, hypnotics, and their metabolites in urine by GC-MS developed using rat liver microsomes; Therapeutic Drug Monitoring, (2001); 23: 61-70. (Pubitemid 32105967)
33. Oztunc, A., Onal, A., Erturk, S.; 7,7,8,8-Tetracyanoquinodimethane as a new derivatization reagent for high-performance liquid chromatography and thin-layer chromatography: Rapid screening of plasma for some antidepressants; Journal of Chromatoraphy B, (2002); 774: 149-155. (Pubitemid 34655486)
34. Titier, K., Castaing, N., Scotto-Gomez, E., Pehourcq, F., Moore, N., Molimard, M.; High-performance liquid chromatographic method with DAD for identification and quantification of eight new antidepressants and five of their active metabolites in plasma after overdose; Therapeutic Drug Monitoring, (2003); 25: 581-587. (Pubitemid 37238892)
35. Duverneuil, C., de la Grandmaison, G.L., de Mazancourt, P., Alvarez, J.C.; A high performance liquid chromatography method with photodiode-Array UV detection for therapeutic drug monitoring of the nontricyclic antidepressant drugs; Therapeutic Drug Monitoring, (2003); 25: 565-573. (Pubitemid 37238890)
36. Rang, H.P., Dale, M.M., Ritter, J.M., Flower, J.M.; Rang & Dale's pharmacology, 6th edition. Elsevier, New York, NY, (2007), pp. 560-568.
37. Drobitch, R.K., Svensson, C.K.; Therapeutic drug monitoring in saliva: An update; Clinical Pharmacokinetics, (1992); 23: 365-379.
38. Drummer, O.H. Review: Pharmacokinetics of illicit drugs in oral fluid; Forensic Science International, (2005); 150: 133-142. (Pubitemid 41583215)
39. Liu, W., Cai, H., Li, H.; High performance liquid chromatographyelectrospray ionization mass spectrometry (HPLC-MS/ESI) method for simultaneous determination of venlafaxine and its three metabolites in human plasma; Journal of Chromatography B, (2007); 850: 405-411. (Pubitemid 46618188)
40. Unceta, N., Alberto, G.C., Alicia, S.; Simultaneous determination of citalopram, fluoxetine and their main metabolites in human urine samples by solid-phase microextraction coupled with highperformance liquid chromatography; Journal of Pharmaceutical and Biomedical Analysis, (2008); 46: 763-770.
41. Pujadas, M., Simona, P., Ester, C., Elena, S., Katherine, P., Rafael, T.; A simple and reliable procedure for the determination of psychoactive drugs in oral fluid by gas chromatography-mass spectrometry; Journal of Pharmaceutical and Biomedical Analysis, (2007); 44: 594-601. (Pubitemid 46880095)
42. He, J., Zhou, Z., Li, H.; Simultaneous determination of fluoxetine, citalopram, paroxetine, venlafaxine in plasma by high performance liquid chromatography-electrospray ionization mass spectrometry (HPLC-MS/ESI); Journal of Chromatography B, (2005); 820: 33-39.
43. Dong, M.W.; Modern HPLC for practicing scientists. John Wiley & Sons, Hoboken, NJ, (2006), pp. 32-39.
44. Rabel, F.M., Caputo, A.G., Butts, E.T.; Separation of carbohydrates on a new polar bonded phase material; Journal of Chromatography, (1976); 126: 731-740.
45. Synder, L.R., Kirkland, J.J.; Introduction to modern liquid chromatography. Wiley, New York, NY, (1979), pp. 286.
46. Fernandez-Navarro, J.J., Garcia-Alvarez-Coque, M.C., Ruiz-Angel, M.J.; The role of the dual nature of ionic liquids in the reversed-phase liquid chromatographic separation of basic drugs; Journal of Chromatography A, (2011); 1218: 398-407.
47. Nene, U.D., Encyclopedia of separation science.Elsevier, New York, NY, (2007), pp. 1-7.
48. Baumann, P.; Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors; Pharmacokinetics, (1996); 31: 444.
49. Lacassie, E., Ragot, S., Gaulier, J.M., Marquet, P., Lachatre, G.; pecific analytical method for the analysis of 24 antidepressants using GC-MS (GC/MS); Acta Clinica Belgica, (1999); 20-24. (Pubitemid 29165550)